SPADARO, Aldo
 Distribuzione geografica
Continente #
EU - Europa 2.117
NA - Nord America 1.780
AS - Asia 883
SA - Sud America 292
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 2
Totale 5.108
Nazione #
US - Stati Uniti d'America 1.749
RU - Federazione Russa 1.143
SG - Singapore 373
BR - Brasile 260
CN - Cina 252
IE - Irlanda 245
SE - Svezia 238
DE - Germania 123
UA - Ucraina 105
HK - Hong Kong 104
GB - Regno Unito 62
FR - Francia 59
FI - Finlandia 58
VN - Vietnam 53
IN - India 30
IT - Italia 27
BE - Belgio 18
CA - Canada 17
BD - Bangladesh 14
AR - Argentina 12
TR - Turchia 9
PK - Pakistan 8
UZ - Uzbekistan 8
ZA - Sudafrica 7
AT - Austria 6
CO - Colombia 6
ES - Italia 6
IQ - Iraq 6
AZ - Azerbaigian 5
KE - Kenya 5
MX - Messico 5
VE - Venezuela 5
MA - Marocco 4
PL - Polonia 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
LT - Lituania 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
EE - Estonia 2
JP - Giappone 2
KZ - Kazakistan 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
PH - Filippine 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BI - Burundi 1
BO - Bolivia 1
BZ - Belize 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LV - Lettonia 1
NL - Olanda 1
NR - Nauru 1
NZ - Nuova Zelanda 1
RO - Romania 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.099
Città #
Moscow 328
Dublin 245
Jacksonville 215
Ashburn 188
Singapore 178
Chandler 176
San Jose 133
Beijing 127
Nyköping 127
Dallas 109
Hong Kong 104
The Dalles 75
Ann Arbor 67
Council Bluffs 66
Los Angeles 58
Munich 42
Cambridge 38
Princeton 37
Lauterbourg 34
Des Moines 31
Medford 30
Lancaster 26
São Paulo 25
Boardman 23
Dearborn 22
Woodbridge 20
Ho Chi Minh City 19
Brussels 18
Buffalo 17
Chennai 13
San Mateo 12
Tianjin 12
Chicago 10
Hanoi 10
Jinan 10
Pune 10
Frankfurt am Main 9
Belo Horizonte 8
Helsinki 8
New York 8
Santa Clara 8
Tashkent 8
Brooklyn 7
Phoenix 7
Redondo Beach 7
Rio de Janeiro 7
Turku 7
Düsseldorf 6
Espoo 6
London 6
Montreal 6
Porto Alegre 6
Baku 5
Mountain View 5
Nairobi 5
Salvador 5
San Francisco 5
Boston 4
Brasília 4
Changsha 4
Haikou 4
Houston 4
Istanbul 4
Lahore 4
Manchester 4
Orem 4
Pelotas 4
Poplar 4
Shanghai 4
Stockholm 4
Atlanta 3
Caruaru 3
Contagem 3
Curitiba 3
Guangzhou 3
Hangzhou 3
Hải Dương 3
Itapevi 3
Joinville 3
Nanjing 3
Naples 3
Ningbo 3
Norwalk 3
Osasco 3
Queens 3
Recife 3
Salerno 3
Santo André 3
Seattle 3
Taizhou 3
Toronto 3
Warsaw 3
Washington 3
Wilmington 3
Abidjan 2
Almaty 2
Aparecida de Goiânia 2
Auburn Hills 2
Baghdad 2
Baltimore 2
Totale 2.930
Nome #
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma 207
High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder. 201
Class I HLA antigens hepatic display and beta-2-microglobulin serum values in chronic hepatitis C: Effect of treatment with recombinant alpha interferon 176
Serum thrombopoietin in chronic liver disease: Relation to severity of the disease and spleen size 175
Serum chromogranin-A in hepatocellular carcinoma: diagnostic utility and limits. 168
Antibodies to hepatitis A virus in Italian patients with chronic liver disease 165
Efficacy of interferon treatment (IFN) in elderly patients with chronic hepatitis C 156
HCV INFECTION, HEPATIC HLA DISPLAY AND COMPOSITION OF THE MONONUCLEAR CELL INFLAMMATORY INFILTRATE IN CHRONIC-ALCOHOLIC LIVER-DISEASE 154
Interferon retreatment of patients with chronic hepatitis C. A long-term follow-up 154
[Behavior of anti-HBc IgM in acute and chronic hepatitis]. 152
High circulating D-dimers are associated with ascites and hepatocellularcarcinoma in liver cirrhosis. 151
Ten year follow-up of patients with chronic hepatitis C treated with interferon 151
A randomized trial of peginterferon alpha-2a with or without ribavirin for HBeAg-negative chronic hepatitis B. 148
Prognostic factors of survival in complicated viral and alcoholic cirrhosis without hepatocellular carcinoma. A retrospective study. 146
Current practice of hepatitis C treatment in Southern Italy. 145
FOCAL LYMPHOCYTIC AGGREGATES IN CHRONIC HEPATITIS-C - OCCURRENCE, IMMUNOHISTOCHEMICAL CHARACTERIZATION, AND RELATION TO MARKERS OF AUTOIMMUNITY 144
Randomised trial of two different daily doses of interferon- alpha versus classical therapy in treatment-naive patients with chronic hepatitis C 139
Does malnutrition affect survival in cirrhosis? 137
Clinical Outcome of HBeAg-Negative Chronic Hepatitis B in Relation to Virological Response to Lamivudine 135
PREVALENCE OF ANTI-HCV ANTIBODIES IN PATIENTS WITH CHRONIC LIVER-DISEASE AND ITS RELATIONSHIP TO HBV AND HDV INFECTIONS 133
Soluble CD30 serum levels before and after treatment with alpha-interferon in patients with chronic hepatitis 133
NON-ALCOHOLIC FATTY LIVER DISEASE: A MULTICENTRE CLINICAL STUDY BY THE ITALIAN ASSOCIATION FOR THE STUDY OF THE LIVER 132
High circulating D-dimers are associated with ascites and hepatocellular carcinoma in liver cirrhosis. 132
Farmaci di più comune uso in gastroenterologia 131
Current practice of hepatitis C treatment in Southern Italy. 131
Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinoma. 130
FULMINANT HEPATIC FAILURE AND AUTOIMMUNE DISORDERS IN PATIENT WITH MULTIPLE SCLEROSIS ON INTERFERON BETA 1A: A FATAL COMBINATION? 124
Cultural representation of newborn feeding 120
Current practice of chronic hepatitis B treatment in Southern Italy. 119
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data 108
Toxicity of IFN plus ribavirin in patients with chronic hepatitis C. A multicenter retrospective study 103
High Serum Resistin in Chronic Viral Hepatitis Is not a Marker of Metabolic Disorder 91
Randomized trial of two different daily doses of alpha-interferon versus classical treatment in naive patients with chronic hepatitis C 89
Premature discontinuation of interferon plus ribavirin for adverse effects: a multicentre survey in 'real world' patients with chronic hepatitis C 88
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: A randomized controlled trial. 88
Re-treatment with interferon plus ribavirin of chronic hepatitis C nonresponders to interferon monotherapy: A meta- analysis of individual patient data 87
Terapia dell'epatite cronica C: 10 anni di esperienze 84
null 81
Totale 5.108
Categoria #
all - tutte 16.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.812


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022203 0 0 0 14 14 3 8 7 4 42 41 70
2022/2023698 48 64 51 35 62 66 7 52 284 5 19 5
2023/2024161 7 32 10 21 16 45 8 16 0 1 0 5
2024/2025829 4 21 14 65 8 19 21 206 175 50 90 156
2025/20262.197 111 117 127 88 172 494 272 326 335 82 37 36
2026/2027221 28 71 93 29 0 0 0 0 0 0 0 0
Totale 5.108